Sirolimus treatment of left ventricular hypertrophy: who, and when?

Simple item page
UDC.coleccionInvestigaciónes_ES
UDC.departamentoCiencias da Saúdees_ES
UDC.endPage2704es_ES
UDC.grupoInvGrupo de Investigación Cardiovascular (GRINCAR)es_ES
UDC.issue22es_ES
UDC.journalTitleEuropean Heart Journales_ES
UDC.startPage2703es_ES
UDC.volume29es_ES
dc.contributor.authorCrespo-Leiro, María Generosa
dc.contributor.authorHermida-Prieto, Manuel
dc.date.accessioned2018-09-05T09:58:08Z
dc.date.available2018-09-05T09:58:08Z
dc.date.issued2008-10-19
dc.descriptionThis editorial refers to "Sirolimus affects ardiomyocytes to reduce left ventricular mass in hear transplant recipients" by S.S. Kushwaha et al., on page 2742es_ES
dc.identifier.citationCrespo-Leiro MG, Hermida-Prieto M. Sirolimus treatment of left ventricular hypertrophy: who, and when?. Eur Heart J. 2008;29(22):2703-2704es_ES
dc.identifier.issn0195-668X
dc.identifier.urihttp://hdl.handle.net/2183/20991
dc.language.isoenges_ES
dc.publisherOxfordes_ES
dc.relation.urihttps://doi.org/10.1093/eurheartj/ehn470es_ES
dc.rightsThis is a pre-copyedited, author-produced version of an article accepted for publication in "European Heart Journal" following peer reviewed. The version of record is avaliable online at Oxford University web page.es_ES
dc.rights.accessRightsopen accesses_ES
dc.titleSirolimus treatment of left ventricular hypertrophy: who, and when?es_ES
dc.typejournal articlees_ES
dspace.entity.typePublication
relation.isAuthorOfPublication36d178fd-10a0-48a2-925d-71d185a50eda
relation.isAuthorOfPublicationc9cbf7c7-2636-46f4-9784-388750fa6cd3
relation.isAuthorOfPublication.latestForDiscovery36d178fd-10a0-48a2-925d-71d185a50eda

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
CrspoLro_Srlimus.pdf
Size:
158.89 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Investigación (FEP)